Gambian deaths: No excuse for drugs that are unsafe

The alert by the World Health Organisation (WHO) over the deaths of 66 Gambian infants, suspected to have been caused by the consumption of contaminated cough syrups made by a Sonepat firm, Maiden Pharmaceuticals, has raised serious questions about the probity of drug manufacturing and regulatory pr

Related Keywords

Gambia ,India ,Mumbai ,Maharashtra ,Bihar ,Sonepat ,Haryana ,Australia ,United Kingdom ,South Africa ,Delhi ,Kala Amb ,Himachal Pradesh ,Gambian ,Alpana Pharma ,Gopal Dabade ,Udhampur Ramnagar ,Aditi Tandon ,Bhai Sawant ,Lentin Commission ,Central Drug Standards Control Organisation ,Drug Administration ,Indian Council Of Medical Research ,Kokate Committee ,World Health Organisation ,Justice Bakhtawar Lentin Commission ,Maiden Pharmaceuticals ,India Drug Action Network ,Maharashtra Health ,Maiden Pharmaceuticals In Sonepat ,Indian Pharmacopoeia Commission ,Indian Pharmaceutical Association ,Drug Controller ,Manufacturing Practices ,All India Drug Action ,Indian Drugs ,Cosmetics Act ,Indian Pharmacopoeia ,Indian Council ,Medical Research ,State Drug Controller ,Digital Vision ,Maharashtra Health Minister Bhai Sawant ,Maharashtra Food ,Haryana Drug Controller , ,